Cas 935459-77-1,N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide

935459-77-1

Post Buying Request

Basic information

Product Name: N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide
Synonyms: N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide
CAS NO:935459-77-1
Molecular Formula:
Molecular Weight: 421.487
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide(935459-77-1)
EPA Substance Registry System: N-(4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide(935459-77-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 935459-77-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

935459-77-1 Suppliers

Recommended suppliers

935459-77-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 935459-77-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,4,5 and 9 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 935459-77:
(8*9)+(7*3)+(6*5)+(5*4)+(4*5)+(3*9)+(2*7)+(1*7)=211
211 % 10 = 1
So 935459-77-1 is a valid CAS Registry Number.

935459-77-1Upstream product

935459-77-1Downstream Products

935459-77-1Relevant academic research and scientific papers

METHODS OF TREATING AMYLOIDOSIS USING ARYL-CYCLOPROPYL DERIVATIVE ASPARTYL PROTEASE INHIBITORS

-

Page/Page column 111-112, (2010/11/27)

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta prote

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 935459-77-1